IL6 and Behcet disease: Taking into account the reports of elevated IL-6 and TNF-α levels in BD patients, it is conceivable that therapeutic interventions that downregulate these cytokine plasma and brain levels in BD patients would, in turn, exhibit therapeutic benefits.